Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Conditions:   Candidemia;   Mycoses;   Fungal Infection;   Fungemia;   Invasive Candidiasis;   Pneumocystis;   Mold Infection;   Invasive Fungal Disease;   Prophylaxis of Invasive Fungal Infections;   Aspergillus Interventions:   Drug: Rezafungin for Injection;   Drug: Posaconazole;   Drug: Fluconazole;   Drug: Trimethoprim-sulfamethoxazole (TMP/SMX);   Drug: Intravenous Placebo;   Drug: Oral Placebo Sponsor:   Cidara Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials